Krempa David

Insider profile

Performance

Overall performance
1.7

Performance over holding periods
1.7
30 days 90 days 120 days
Average return 3% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
3 0% Buy
34 71% Buy
47 69% Buy
Krempa David's trades of Eton Pharmaceuticals Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2026-05-27 2026-05-27 S Sale
94,771 +31.4%
319.29
US$3,246,653
94,771 +31.4% 319.29 US$3,246,653
2026-05-27 2026-05-26 S Sale
7,108 -28.9%
293.50
US$1,082,979
7,108 -28.9% 293.50 US$1,082,979
2026-05-27 2026-05-22 S Sale
21,759 -36.9%
210.79
US$1,170,688
21,759 -36.9% 210.79 US$1,170,688
2026-05-27 2026-05-22 S Sale
9,315 -26.6%
33.88
US$315,594
9,315 -26.6% 33.88 US$315,594
2026-05-27 2026-05-22 S Sale
32,963 -48.4%
33.22
US$1,095,057
32,963 -48.4% 33.22 US$1,095,057
2026-05-22 2026-05-22 PrS Proposed sale
100,000
35.00
US$3,500,000
100,000 35.00 US$3,500,000
2026-01-14 2026-01-14 PrS Proposed sale
1,942
15.62
US$30,334
1,942 15.62 US$30,334
2025-12-12 2025-12-12 PrS Proposed sale
7,545
16.88
US$127,360
7,545 16.88 US$127,360
2025-06-16 2025-06-16 S Sale
10,223 -1.6%
14.73
US$150,585
10,223 -1.6% 14.73 US$150,585
2025-06-16 2025-06-13 S Sale
6,800 -1.1%
14.77
US$100,436
6,800 -1.1% 14.77 US$100,436
2025-06-16 2025-06-12 S Sale
16,977 -2.6%
14.92
US$253,297
16,977 -2.6% 14.92 US$253,297
2025-06-12 2025-06-12 PrS Proposed sale
40,000
15.00
US$600,000
40,000 15.00 US$600,000